| 查看: 594 | 回复: 3 | |||
[交流]
【交流】从发表论文水平看算什么水平。。新手求助 已有2人参与
|
|
Books/Book Chapters 1. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. “The Principles and Methods of New Drug Design” 1st Edition, China Medical Science and Technology Publishing House, Jul. 1997 2. Xu, Wenfang; Zhao, Guisen; Zhang, Shijun. “The Principles and Methods of New Drug Design” 2d Edition, Science Publishing House, Oct. 2000 Recent Publications Lenhart, J.A.; Ling, X.; Gandhi, R.; Guo, T.L.; Gerk, P.M.; Brunzell, D.H.; Zhang, S. "Clicked" Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Abeta Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. J. Med. Chem. 2010, 53, 6198-6209. Li, Q.; Wu, J.; Zheng, H.; Liu, K.; Guo, T.L.; Liu, Y.; Eblen, S.T.; Grant, S.; Zhang, Shijun. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. & Med. Chem. Lett. 2010, 20, 4526-4530. Zhang, Shijun; Yekkirala, Ajay; Tang, Ye; Portoghese, Philip S. A bivalent ligand (KMN-21) antagonist for µ/? heterodimeric opioid receptors. Bioorg & Med. Chem. Lett. 2009, 19, 6978-6980. Li, Qianbin; Al-Ayoubi, Adnan; Guo, Tailiang; Zheng, Hui; Sarkar, Aurijit; Nguyen, Tri; Eblen, Scott T.; Grant, Steven; Kellogg, Glen E.; Zhang, Shijun. Structure-activity relationship (SAR) studies of 3-(2- amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: Development of potential substrate-specific ERK1/2 inhibitors. Bioorg & Med. Chem. Lett. 2009, 19, 6042-6046. Zhang, Shijun; Fernandez, Fernando; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Further structural exploration of tri-substituted asymmetric pyran derivaives, (2S, 4R, 5R)-2-benzhydryl-5- benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S, 6S)-pyran derivatives: A proposed pharmacohpore model for high affinity interaction with the dopamine, serotonin, and norepinephrine transporters. J. Med. Chem. 2006, 49, 4239-4237. Zhang, Shijun; Zhen, Juan; Reith, Maarten E. A.; Dutta, Aloke K.. Design, Synthesis, and Preliminary SAR Study of 3-and 6-Sides-Chain Extended Tetrahydro-Pyran Analogues of cis- and trans-(6- benzhydryl-piperidin-3-yl)-benzylamine. Bioorg. & Med. Chem. 2006, 14, 3953- 3966. Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Discovery of novel tri-substituted asymmetric pyran derivatives, (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner. J. Med. Chem. 2005, 48, 4962-4971. Zhang, Shijun; Zhen, Juan; Reith, Maarten E.A.; Dutta, Aloke K.. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters. Bioorg. & Med. Chem. 2004, 12, 6301- 6315. Dutta, Aloke K.; Venkataraman, Sylesh K.; Fei, Xiang-shu; Kolhatkar, Rohit; Zhang, Shijun; Reith,Maarten E.A.. Synthesis and biological characterization of novel hybrid 7-{[2-(4-phenylpiperazin- 1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol analogues for the dopamine D2 and D3 receptors. Bioorg. & Med. Chem. 2004, 12, 4361- 4373. Dutta, Aloke K.; Zhang, Shijun; Kohhatkar, Rohit; Reith, Maarten E.A.. Dopamine Transporter as Target for Drug Development of Cocaine Dependence Medications. Europ. J. Pharmacol. 2003, 479, 93-106. Zhang, Shijun; Reith, Maarten E.A.; Dutta, Aloke K.. Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter. Bioorg. & Med. Chem. Lett. 2003, 13, 1591-1595. |
回复此楼» 猜你喜欢
售SCI一区T0P文章，我:8O.55.1.O.54,科目全,可伽急
已经有14人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.5.4,科目全,可+急
已经有19人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有24人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.54,科目齐全,可+急
已经有11人回复
-
售SCI一区文章，我:8O5.5.1.O5.4,科目全,可伽急
已经有5人回复
-
售SCI一区文章，我:8.O.55.1.O.54,科目齐全,可伽急
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有5人回复
-
售SCI-T0P文章，我:8O.5.5.1.O.54,科目齐全,可+急
已经有10人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 论文被退回，说是英文水平达不到要求，求助高人哪里有较好的论文修改公司？
已经有9人回复
- 计算机专业发一篇sci算什么水平
已经有12人回复
- 【课件】高水平论文发表技巧（中南大学）
已经有97人回复
- 新手求助：如何写论文，如何做实验
已经有3人回复
- 【求助】未发表的论文能给同行看吗
已经有12人回复
- 求助：没有论文基础，如何选计算机类的科研方向，如何写出高水平的论文？
已经有12人回复
- 【求助】用materials studio算东西发表论文时参考文献应该怎么写？
已经有3人回复
- 高职院校教师如何发表高水平的学术论文呢？
已经有19人回复
jiangchunyong
荣誉版主 (文坛精英)
-
专家经验: +2 - PhEPI: 2
- 应助: 132 (高中生)
- 贵宾: 2.626
- 金币: 34018.5
- 散金: 183
- 红花: 44
- 沙发: 21
- 帖子: 14820
- 在线: 1602.6小时
- 虫号: 490643
- 注册: 2008-01-03
- 专业: 药物化学
- 管辖: 药学
2楼2011-03-27 21:41:06
3楼2011-03-27 21:45:31
jiangchunyong
荣誉版主 (文坛精英)
-
专家经验: +2 - PhEPI: 2
- 应助: 132 (高中生)
- 贵宾: 2.626
- 金币: 34018.5
- 散金: 183
- 红花: 44
- 沙发: 21
- 帖子: 14820
- 在线: 1602.6小时
- 虫号: 490643
- 注册: 2008-01-03
- 专业: 药物化学
- 管辖: 药学
4楼2011-03-27 21:48:13
50